Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease dermatomyositis
Comorbidity C0024115|lung disease
Sentences 25
PubMedID- 22931947 Objective: to explore the clinical and laboratory features and the prognosis of juvenile dermatomyositis (jdm) complicated with interstitial lung disease (ild).
PubMedID- 24142786 [interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases].
PubMedID- 26459323 The objective of this study is to assess serum il8 and the potential activity of circulating neutrophils on relative messenger rna (mrna) levels and their relationship with disease activity in clinically amyopathic dermatomyositis (cadm) associated with interstitial lung disease (ild).
PubMedID- 21285059 Interstitial lung disease associated with polymyositis/dermatomyositis (ild-pm/dm) often confers a poor prognosis, and optimal treatment of this condition is not well defined.
PubMedID- 23158422 Objective: to explore the possible diagnostic values of serum surfactant protein-a (sp-a) and surfactant protein-d (sp-d) for interstitial lung diseases (ild) in patients with polymyositis or dermatomyositis (pm/dm).
PubMedID- 23569020 Objective: : to study the clinical features of interstitial lung disease (ild) in patients with dermatomyositis and factors related to its development.
PubMedID- 25346167 Anti-transcription intermediary factor 1-gamma antibody-positive clinically amyopathic dermatomyositis complicated by interstitial lung disease and breast cancer.
PubMedID- 25888887 Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis.
PubMedID- 25698373 Rapidly progressive interstitial lung disease (rp-ild) in patients with clinically amyopathic dermatomyositis (cadm) associated with antibodies to melanoma differentiation-associated gene5 (mda5) results in a high mortality rate.
PubMedID- 25622670 Objective: to explore the clinical features and prognosis of dermatomyositis patients with interstitial lung disease (ild) as an initial manifestation.
PubMedID- 20506189 Conclusion: these promising data indicate that mycophenolate mofetil may be a useful therapy for interstitial lung disease in patients with dermatomyositis, but larger studies are needed to more definitively evaluate the role of this medication in therapy.
PubMedID- 26328651 Rapidly progressive interstitial lung disease (ild) is associated with dermatomyositis (dm) and has a high mortality rate even with immunosuppressive agents.
PubMedID- 20827201 A rare form of ild with a very poor prognosis, acute and rapidly progressive lung disease, is strongly associated with clinically amyopathic dermatomyositis (cadm) and a novel - anti-cadm-140 auto-antibody.
PubMedID- 20800454 Serum tarc/ccl17 levels are increased in dermatomyositis associated with interstitial lung disease.
PubMedID- 22863719 Pilot study of interleukin-27 in pathogenesis of dermatomyositis and polymyositis: associated with interstitial lung diseases.
PubMedID- 23423441 This diagnosis should always come to mind in patients that present with signs of myositis, dermatomyositis, or polymyositis associated with interstitial lung disease.
PubMedID- 22781896 [a clinical analysis of dermatomyositis with interstitial lung disease in 20 patients].
PubMedID- 25433590 [interstitial lung disease-associated with amyopathic dermatomyositis and anti-mda5 autoantibodies].
PubMedID- 24325117 Objective: to investigate the clinical features and risk factors associated with interstitial lung disease (ild) in patients with classic dermatomyositis (classic dm) or clinical amyopathic dermatomyositis (cadm).
PubMedID- 23400027 Limitations to the 6-minute walk test in dermatomyositis with interstitial lung disease in comparison with idiopathic interstitial pneumonia.
PubMedID- 23908005 Objective: to assess the utility of anti-melanoma differentiation-associated gene 5 (anti-mda5) antibody measurement for predicting a risk for developing rapidly progressive interstitial lung disease (rp-ild) in patients with polymyositis/dermatomyositis (pm/dm).
PubMedID- 23257529 We herein report the clinical and laboratory characteristics of two anti-oj (anti-isoleucyl-trna synthetase) autoantibody-positive interstitial lung disease patients with polymyositis/dermatomyositis (pm/dm).
PubMedID- 21748914 Subsequently, a diagnosis of amyopathic dermatomyositis with interstitial lung disease and pneumomediastinum was made.
PubMedID- 26101728 Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.
PubMedID- 22325787 Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease.

Page: 1